期刊
PHARMACOTHERAPY
卷 31, 期 9, 页码 871-876出版社
WILEY
DOI: 10.1592/phco.31.9.871
关键词
vancomycin; children; pharmacokinetics; methicillin-resistant Staphylococcus aureus; MRSA
资金
- National Institute of General Medical Sciences [T32 GM07546]
- National Institute of Child Health and Human Development [T32 HD044331]
Study Objective. To evaluate the impact of a hospitalwide increase in the recommended vancomycin starting dose from 45 to 60 mg/kg/day on initial vancomycin trough concentrations in children suspected of having an invasive methicillin-resistant Staphylococcus aureus (MRSA) infection. Design. Retrospective medical record review. Setting. Dedicated children's hospital located in a tertiary care, academic medical center. Patients. A total of 182 children aged 1 month-12 years with normal renal function who had suspected MRSA infections treated with vancomycin during two different starting dose recommendation periods: 45 mg/kg/day divided every 8 hours during July 2006 June 2007 (low-dose group [88 children]) and 60 mg/kg/day divided every 6 hours during July 2008 June 2009 (high-dose group [94 children]). Measurement and Main Results. Data on patient demographics, vancomycin doses, and initial vancomycin trough concentrations were collected. No significant demographic differences were noted between patients in the low-dose and high-dose groups. The mean +/- SD initial vancomycin trough level increased from 7 +/- 5 mu g/ml in the low-dose group to 9 +/- 5 mu g/ml in the high-dose group (p<0.001). The percentage of patients with an initial trough level less than 5 mu g/ml declined from 38% (33/88 children) in the low-dose group to 17% (16/94 children) in the high-dose group (p<0.001), whereas the percentage of patients with an initial trough concentration in the potentially adverse range (> 20 mu g/ml) did not change between the two groups (2% vs 2%, p=0.9). Less than 14% (13/94 children) achieved a trough level in the range of 15-20 mu g/ml in the high-dose group. Conclusion. An increase in the recommended vancomycin starting dose to 60 mg/kg/day decreased the likelihood of an initial low vancomycin trough level (< 5 mu g/ml), with no increase in the proportion of patients with trough levels in a potentially toxic range. The 60-mg/kg/day dose did not consistently achieve a vancomycin trough of 15-20 mu g/ml, a goal suggested by some experts for adults. Comparative effectiveness studies are needed to directly evaluate vancomycin dosing regimens and clinical outcomes for children with invasive MRSA infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据